Anika Therapeutics ANIK Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's software and technology licenses, net?
- Anika Therapeutics (ANIK) reported software and technology licenses, net of $4.3M in Q1 2026.
- How has Anika Therapeutics's software and technology licenses, net changed year-over-year?
- Anika Therapeutics's software and technology licenses, net decreased by 24.8% year-over-year, from $5.73M to $4.3M.
- What is the long-term trend for Anika Therapeutics's software and technology licenses, net?
- Over 5 years (2020 to 2025), Anika Therapeutics's software and technology licenses, net has grown at a -23.5% compound annual growth rate (CAGR), from $15.42M to $4.03M.